5 Towards cannabinoid drugs (Q57363657)

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

Drugs related to tetrahydrocannabinol

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

The religious and medicinal uses of Cannabis in China, India and Tibet

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

Some historical aspects of marijuana

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

1 reference

7 January 2021

A new euphoriant for depressive mental states.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

Psychological effects in depressive patients of the marihuana homologue synhexyl

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

Pharmacology of marijuana

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

Potential Therapeutic Usefulness of Marijuana

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

1 reference

7 January 2021

Behavioral comparisons of the stereoisomers of tetrahydrocannabinols.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

Psychopharmacological activity of the active constituents of hashish and some related cannabinoids

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

The ring test: a quantitative method for assessing the ‘cataleptic’ effect of cannabis in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

Characteristics of tetrahydrocannabinol (THC)-produced discrimination in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

A repeated test procedure to assess onset and duration of the cue properties of (-) delta 9-THC, (-) delta 8-THC-DMH and (+) delta 8-THC.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

Interactions between delta 9-tetrahydrocannabinol and cannabidiol as evaluated by drug discrimination procedures in rats and pigeons.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

The role of benzodiazepine receptors in the discriminative stimulus properties of delta-9-tetrahydrocannabinol.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

A cannabinoid derived prototypical analgesic

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

Benzoxocin and benzoxonin derivatives. Novel groups of terpenophenols with central nervous system activity

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

Benzoxocin and benzoxonin derivatives. Novel groups of terpenophenols with central nervous system activity. Correction

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

Cannabinoids. 1. 1-Amino- and 1-mercapto-7,8,9,10-tetrahydro-6H-dibenzo [b,d]pyrans

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

Cannabinoids. Structure-activity studies related to 1,2-dimethylheptyl derivatives.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

Identification through synthesis of an active delta-1(6)-tetrahydrocannabinol metabolite

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

6β-Hydroxy-Δ 1 -Tetrahydrocannabinol Synthesis and Biological Activity

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

Synthesis and biological activity of five tetrahydrocannabinol metabolites

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

Delta 6-tetrahydrocannabinol-7-oic acid, a urinary delta 6-THC metabolite: isolation and synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

Structure-activity relationships in man of cannabis constituents, and homologs and metabolites of delta9-tetrahydrocannabinol

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

Stereochemical requirements for cannabinoid activity

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

Activity of novel aminocannabinoids in baboons

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

9-Nor-.DELTA.8-tetrahydrocannabinol, a cannabinoid of metabolic interest

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

9-Nor-9-hydroxyhexahydrocannabinols. Synthesis, Some behavioral and analgesic properties, and comparison with the tetrahydrocannabinols

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

The absolute configuration of δ1-tetrahydrocannabinol, the major active constituent of hashish

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

Stereospecific synthesis of (-)-.DELTA.1- and (-)-.DELTA.1(6)-tetrahydrocannabinols

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

Relative pharmacological potency in mice of optical isomers of delta 1-tetrahydrocannabinol.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

Differential scanning calorimetry and enzymic activity of rat liver microsomes in the presence and absence of delta1-tetrahydrocannabinol

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

The interaction of hashish compounds with planar lipid bilayer membranes (BLM).

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

The dimethylheptyl derivative of (−)-Δ8-tetrahydrocannabinol reduces the turnover rate of gamma-aminobutyric acid in the septum and nucleus accumbens

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

Reduction of hippocampal acetylcholine turnover in rats treated with (-)-delta 8-tetrahydrocannabinol and its 1',2'-dimethyl-heptyl homolog

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

Regional brain homovanillic acid following delta 9-tetrahydrocannabinol and cocaine.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

Enhancement of brain [3H]flunitrazepam binding and analgesic activity of synthetic cannabimimetics

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

Antianxiety effect of cannabis: involvement of central benzodiazepine receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

Involvement of brain histamine in delta 9-tetrahydrocannabinol tolerance and withdrawal.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

Evidence for the existence of specific cannabinoid binding sites.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

A clinical and metabolic study of acute intoxication with Cannabis sativa and its role in the model psychoses

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

Tetrahydrocannabinol analogs. Synthesis of 2-(3-methyl-2-octyl)-3-hydroxy-6,6,9-trimethyl-7,8,9,10-tetrahydrodibenzo(b,d)pyran

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

Analgesic activity of 9 -tetrahydrocannabinol in the rat and mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

Pharmacological interaction between cannabidiol and delta 9-tetrahydrocannabinol

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

Comparative analgesic activity of various naturally occurring cannabinoids in mice and rats

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

Structural requirements for cannabinoid-induced antinociceptive activity in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

Effect of oral administration of Δ9 tetrahydrocannabinol on memory, speech, and perception of thermal stimulation: Results with four normal human volunteer subjects. Preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

The analgesic properties of delta-9-tetrahydrocannabinol and codeine

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

Analgesic Effect of Delta‐9‐Tetrahydrocannabinol

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

Effects of intravenous tetrahydrocannabinol on experimental and surgical pain. Psychological correlates of the analgesic response

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

Action of cannabidiol on the anxiety and other effects produced by delta 9-THC in normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

Effect of a nitrogen analog of tetrahydrocannabinol on cancer pain

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

Analgesic properties of the tetrahydrocannabinols, their metabolites, and analogs

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

Selective and Potent Analgetics Derived from Cannabinoids

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

Prototype cannabinoid analgetics, prostaglandins and opiates — A search for points of mechanistic interaction

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

A pharmacological analysis of levonantradol antinociception in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

An assessment of the role of opioid receptors in the response to cannabimimetic drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

Cannflavin A and B, prenylated flavones from Cannabis sativa L

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

Central pontine myelinolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

Antiemetic Effect of Delta-9-Tetrahydrocannabinol in Patients Receiving Cancer Chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

Hormonal changes induced by a partial opiate antagonist, nalorphine. Evaluation of PRL, GH, TSH, LH, FSH and cortisol secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

Antiemetic Activity of N-Methyllevonantradol and Nabilone in Cisplatin-Treated Cats

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

Attenuation of cyclophosphamide-induced taste aversions in mice by prochlorperazine, delta 9-tetrahydrocannabinol, nabilone and levonantradol

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

The pharmacologic profile of nabilone: a new antiemetic agent

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

Antiemetics in patients receiving chemotherapy for cancer: a randomized comparison of delta-9-tetrahydrocannabinol and prochlorperazine

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

Delata-9-tetrahydrocannabinol as an antiemetic in cancer patients receiving high-dose methotrexate. A prospective, randomized evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

Plasma delta-9-tetrahydrocannabinol concentrations and clinical effects after oral and intravenous administration and smoking

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

Nabilone and prochlorperazine: a useful combination for emesis induced by cytotoxic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

Cannabinoids. 3. Synthetic approaches to 9-ketocannabinoids. Total synthesis of nabilone

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

Clinical pharmacology of nabilone, a cannabinol derivative

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

Superiority of Nabilone over Prochlorperazine as an Antiemetic in Patients Receiving Cancer Chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

Levonantradol for Chemotherapy‐Induced Emesis: Phase I—II Oral Administration

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

Antiemetic effect of intramuscular levonantradol in patients receiving anticancer chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

The cannabinoids as potential antiepileptics

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

Antiepileptic Potential of Cannabidiol Analogs

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

Anticonvulsant effects of the (-) and (+)isomers of cannabidiol and their dimethylheptyl homologs

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

Subacute cannabinoid treatment: anticonvulsant activity and withdrawal excitability in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

Influence of 22-day treatment on the anticonvulsant properties of cannabinoids

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

Effects of cannabidiol on behavioral seizures caused by convulsant drugs or current in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

Anticonvulsant activity of Δ9-tetrahydrocannabinol compared with three other drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

Central excitatory properties of Δ9-tetrahydrocannabinol and its metabolites in iron-induced epileptic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

Effects of marihuana cannabinoids on seizure activity in cobalt-epileptic rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

The Influence of Cannabidiol and Δ9-Tetrahydrocannabinol on Cobalt Epilepsy in Rats

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

Antiepileptic and Prophylactic Effects of Tetrahydrocannabinols in Amygdaloid Kindled Cats

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

An Electrophysiological Analysis of the Anticonvulsant Action of Cannabidiol on Limbic Seizures in Conscious Rats

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

Chronic administration of cannabidiol to healthy volunteers and epileptic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

The ocular effects of cannabinoids

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

Marihuana Smoking and Intraocular Pressure

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

Advances in Ocular Pharmacology

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

Effect of marihuana on intraocular and blood pressure in glaucoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

Ocular hypotension, ocular toxicity, and neurotoxicity in response to marihuana extract and cannabidiol.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

Topical Δ9-Tetrahydrocannabinol and Aqueous Dynamics in Glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

Multiple-drop study of topically applied 1% delta 9-tetrahydrocannabinol in human eyes

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

Topical Δ9-tetrahydrocannabinol in hypertensive glaucomas

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

A comparison of topical cannabinoids on intraocular pressure

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

Intraocular pressure, ocular toxicity and neurotoxicity after administration of cannabinol or cannabigerol

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

Isolation of Ocular Hypotensive Agents From Cannabis sativa

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

Marihuana-derived material: distribution and effects after systemic administration

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

Marihuana-derived material: biochemical studies of the ocular responses

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

Ocular and systemic responses to water soluble material derived from Cannabis sativa (marihuana)

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

Effect of 1 -tetrahydrocannabinol on aqueous dynamics and ciliary body permeability in the rabbit

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

Tetrahydrocannabinol as a bronchodilator. Why bother

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

Bronchodilator effect of delta1-tetrahydrocannabinol administered by aerosol of asthmatic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

Pharmacology of orally administered Δ9-tetrahydrocannabinol

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

Respiratory status of seventy-four habitual marijuana smokers

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

Editorial: The smoke in marihuana smoking

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

Bronchodilator effect of delta1-tetrahydrocannabinol

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

Acute and subacute bronchial effects of oral cannabinoids.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

The effects of Δ9-tetrahydrocannabinol and nabilone on the isolated guinea pig bronchus

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

Cannabidiol interferes with the effects of Δ9-tetrahydrocannabinol in man

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

Comparison of Bronchial Effects of Nabilone and Terbutaline in Healthy and Asthmatic Subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

On the Definition of Cannabinoids: Botanical? Chemical? Pharmacological?

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

Solid dispersion approach for overcoming bioavailability problems due to polymorphism of nabilone, a cannabinoid derivative

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021

Antiepileptic and Prophylactic Effects of Tetrahydrocannabinols in Amygdaloid Kindled Rats

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970422-3

7 January 2021